EXEGENICS INC has a total of 13 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CELLCEUTIX CORP, LATVIJAS ORGANISKAS SINTEZES I and WELLCOME FOUND.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Canada | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Israel | 1 | |
#6 | Mexico | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Basic materials chemistry | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Arad Dorit | 9 |
#2 | Bollon Arthur P | 6 |
#3 | Peek Andrew S | 5 |
#4 | Poland Bradley W | 4 |
#5 | Young David C | 3 |
#6 | Av-Gay Yossef | 3 |
#7 | Berent Susan L | 1 |
#8 | Shaw Bailin | 1 |
#9 | Reich Samuel Jotham | 1 |
#10 | Elias Yuval | 1 |
Publication | Filing date | Title |
---|---|---|
AU2003256290A8 | Antimicrobial compounds | |
AU2003224881A1 | Antimicrobial compounds against staphylococci, mycobacteria, and other infectious agents | |
WO02068445A1 | Antisense nucleic acid inhibitors of mycothiol production in mycobacterium tuberculosis | |
AU2002305926A1 | Cysteine protease inhibitors |